Pangenomic Health Inc. (NARA.CN)
CAD 0.14
(0.0%)
CAD 0.14
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 952.18 Thousand CAD | 7089.02% |
| 2022 | 13.24 Thousand CAD | 100.98% |
| 2021 | -1.34 Million CAD | -12472.22% |
| 2020 | -10.72 Thousand CAD | -378.24% |
| 2019 | -2243.00 CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -13.9 Thousand CAD | -101.48% |
| 2024 Q1 | 936.59 Thousand CAD | -1.64% |
| 2023 Q1 | 133.58 Thousand CAD | 908.58% |
| 2023 FY | 952.18 Thousand CAD | 7089.02% |
| 2023 Q4 | 952.18 Thousand CAD | 54.92% |
| 2023 Q3 | 614.63 Thousand CAD | 22.93% |
| 2023 Q2 | 499.99 Thousand CAD | 274.29% |
| 2022 Q1 | -729.02 Thousand CAD | 45.94% |
| 2022 FY | 13.24 Thousand CAD | 100.98% |
| 2022 Q4 | 13.24 Thousand CAD | 147.11% |
| 2022 Q3 | -28.11 Thousand CAD | 97.76% |
| 2022 Q2 | -1.25 Million CAD | -72.15% |
| 2021 Q3 | 544.43 Thousand CAD | 0.0% |
| 2021 Q1 | 38.22 Thousand CAD | 456.36% |
| 2021 Q4 | -1.34 Million CAD | -347.71% |
| 2021 FY | -1.34 Million CAD | -12472.22% |
| 2020 FY | -10.72 Thousand CAD | -378.24% |
| 2020 Q4 | -10.72 Thousand CAD | 0.0% |
| 2019 FY | -2243.00 CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AI/ML Innovations Inc. | -3732.00 CAD | 25614.094% |
| Diagnamed Holdings Corp. | -606.96 Thousand CAD | 256.877% |
| nDatalyze Corp. | -794.1 Thousand CAD | 219.907% |
| Treatment.Com International Inc. | -273.39 Thousand CAD | 448.283% |
| Unidoc Health Corp. | -324.03 Thousand CAD | 393.857% |